Of the patients with local tumor detection and lymph node metastases, 23/37 (62.2%) received locally applicable treatments, considerably fewer patients than in the groups with lower PSA values. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.